amiloride has been researched along with Retinal Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chaudhry, A; Chintala, SK; Zhang, X | 1 |
| Babovic, A; Drolsum, A; Eide, IK; Lilledahl, NP; Torjesen, PA | 1 |
1 trial(s) available for amiloride and Retinal Diseases
| Article | Year |
|---|---|
Low-renin status in therapy-resistant hypertension: a clue to efficient treatment.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Amiloride; Antihypertensive Agents; Cross-Over Studies; Drug Combinations; Drug Resistance; Female; Humans; Hydrochlorothiazide; Hyperaldosteronism; Hypertension; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Potassium; Prevalence; Prospective Studies; Renin; Retinal Diseases | 2004 |
1 other study(ies) available for amiloride and Retinal Diseases
| Article | Year |
|---|---|
Inhibition of plasminogen activation protects against ganglion cell loss in a mouse model of retinal damage.
Topics: alpha-2-Antiplasmin; Amiloride; Animals; Apoptosis; Blotting, Western; Cell Survival; Cytoprotection; Fibrinolysin; Immunoenzyme Techniques; In Situ Nick-End Labeling; Laminin; Ligation; Mice; Optic Nerve; Plasminogen; Plasminogen Activators; Plasminogen Inactivators; Reperfusion Injury; Retinal Diseases; Retinal Ganglion Cells; Serine Proteinase Inhibitors; Tissue Plasminogen Activator; Urokinase-Type Plasminogen Activator | 2003 |